u/aleksi_lehtinen

Yeah, maintenance is the boring part and the important part.

I am going to push back on this slightly.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Poland here. Waited 18 months on a list, gave up, went private, and the total cost was roughly what I expected.

Did the reflux start before or after the dose increase?

The injection-site soreness passes. I kept a log and the timeline was the only useful thing. 15 weeks and it was basically gone.

receipts or nothing, sorry but that is the rule

SSA order #5, Canada, no drama, receipts inside

The early fullness was genuinely awful for three weeks and then simply stopped. I know that is not useful information, but it is what happened.

the 17-day half-life means week 17 is still ramp-up pharmacokinetically

Show the arithmetic.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

Cored the stopper on my 13th draw because I kept using the same entry point. Rotate the puncture site.

Disagree but this is the good kind of wrong — it is specific enough to be checked.

receptor distribution matters, GLP-1 is not everywhere

Not to be pedantic but sulphur burps and reflux are being used interchangeably and they are not interchangeable in real life.

bacteriostatic and sterile water are not interchangeable, do not use them that way

How many orders from ERP is that a sample of? One reship is noise, five is a pattern.

order date, product, and what was tested. that is the template.

This is correct. Rodent data is investigational, not predictive.

Disagree but this is the good kind of wrong — it is specific enough to be checked.